Teladoc Health, Inc. (TDOC) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TDOC currently has 177M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 4.45% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Oct 30, 2025 |
10-Q filing | 176.9M shares outstanding |
180M | 0 |
| May 01, 2025 |
10-Q filing | 174.2M shares outstanding |
170M | 0 |
| Feb 27, 2025 |
10-K filing | 170.6M shares outstanding |
170M | 0 |
| Oct 31, 2024 |
10-Q filing | 171.5M shares outstanding |
170M | 0 |
| Aug 01, 2024 |
10-Q filing | 170.2M shares outstanding |
170M | 0 |
| Apr 26, 2024 |
10-Q filing | 167.7M shares outstanding |
170M | 0 |
| Feb 23, 2024 |
10-K filing | 164.6M shares outstanding |
160M | 0 |
| Oct 27, 2023 |
10-Q filing | 165.1M shares outstanding |
170M | 0 |
| Jul 28, 2023 |
10-Q filing | 164.2M shares outstanding |
160M | 0 |
| May 02, 2023 |
10-Q filing | 162.9M shares outstanding |
160M | 0 |
| Mar 01, 2023 |
10-K filing | 161.5M shares outstanding |
160M | 0 |
| Nov 02, 2022 |
10-Q filing | 161.7M shares outstanding |
160M | 0 |
| Aug 03, 2022 |
10-Q filing | 161.4M shares outstanding |
160M | 0 |
| May 02, 2022 |
10-Q filing | 160.5M shares outstanding |
160M | 0 |
| Feb 28, 2022 |
10-K filing | 156.9M shares outstanding |
160M | 0 |
| Nov 01, 2021 |
10-Q filing | 160.0M shares outstanding |
160M | 0 |
| Aug 16, 2021 |
8-K filing: Teladoc Health, Inc. entered into exchange agreements with certain holders of its 2025 Notes, exchanging $774,000 aggregate principal amount of 2025 Notes for 14,593 shares of the Company's common stock. |
160M | 0 |
| Aug 04, 2021 |
8-K filing: Teladoc Health, Inc. entered into exchange agreements with certain holders of its 2025 Notes, exchanging $4,301,000 aggregate principal amount of 2025 Notes for an aggregate of 80,999 shares of the Company's common stock. The closing of the Exchange Transactions is expected to occur on or about August 5, 2021. |
160M | 0 |
| Aug 02, 2021 |
10-Q filing | 159.5M shares outstanding |
160M | 0 |
| Jun 17, 2021 |
8-K filing: Teladoc Health, Inc. entered into exchange agreements to exchange $7,948,000 aggregate principal amount of 2025 Notes for an aggregate of 149,587 shares of the Company's common stock. |
150M | 0 |
| May 27, 2021 |
8-K filing: Teladoc Health, Inc. entered into exchange agreements to exchange $198,490,000 aggregate principal amount of 2025 Notes for an aggregate of 3,736,313 shares of the Company's common stock. The closing of the Exchange Transactions is anticipated to occur on or about June 1, 2021. |
150M | 0 |
| May 03, 2021 |
10-Q filing | 154.4M shares outstanding |
150M | 0 |
| Mar 01, 2021 |
10-K filing | 72.8M shares outstanding |
73M | 0 |
| Nov 06, 2020 |
10-Q filing | 84.4M shares outstanding |
84M | 0 |
| Jul 29, 2020 |
10-Q filing | 79.1M shares outstanding |
79M | 0 |
| May 19, 2020 |
8-K filing: Teladoc Health, Inc. issued $1 billion aggregate principal amount of 1.25% Convertible Senior Notes due 2027 and exchanged $228.2 million aggregate principal amount of 2022 Notes for approximately 3.9 million shares of common stock and $231.1 million in cash. |
74M | 0 |
| Apr 29, 2020 |
10-Q filing | 74.1M shares outstanding |
74M | 0 |
| Feb 26, 2020 |
10-K filing | 70.5M shares outstanding |
71M | 0 |